Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 654

1.

Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis.

Zhou F, Bisgard KM, Yusuf HR, Deuson RR, Bath SK, Murphy TV.

Pediatrics. 2002 Oct;110(4):653-61.

PMID:
12359777
2.

Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.

Zhou F, Santoli J, Messonnier ML, Yusuf HR, Shefer A, Chu SY, Rodewald L, Harpaz R.

Arch Pediatr Adolesc Med. 2005 Dec;159(12):1136-44.

PMID:
16330737
3.

Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in Indonesia.

Gessner BD, Sedyaningsih ER, Griffiths UK, Sutanto A, Linehan M, Mercer D, Mulholland EK, Walker DG, Steinhoff M, Nadjib M.

Pediatr Infect Dis J. 2008 May;27(5):438-43. doi: 10.1097/INF.0b013e318165f1ba.

PMID:
18398383
4.

Cost-benefit analysis of haemophilus influenzae type B immunization in Korea.

Shin S, Shin YJ, Ki M.

J Korean Med Sci. 2008 Apr;23(2):176-84. doi: 10.3346/jkms.2008.23.2.176.

5.

Cost-benefit analysis for the use of Haemophilus influenzae type b conjugate vaccine in Santiago, Chile.

Levine OS, Ortiz E, Contreras R, Lagos R, Vial P, Misraji A, Ferreccio C, Espinoza C, Adlerstein L, Herrera P, et al.

Am J Epidemiol. 1993 Jun 1;137(11):1221-8.

PMID:
8322763
6.

An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.

Zhou F, Reef S, Massoudi M, Papania MJ, Yusuf HR, Bardenheier B, Zimmerman L, McCauley MM.

J Infect Dis. 2004 May 1;189 Suppl 1:S131-45.

PMID:
15106102
7.

An assessment of the value of Haemophilus influenzae type b conjugate vaccine in Asia.

Miller MA.

Pediatr Infect Dis J. 1998 Sep;17(9 Suppl):S152-9.

PMID:
9781750
8.

Cost-benefit analysis of Haemophilus influenzae type b vaccination in children in Spain.

Jiménez FJ, Guallar-Castillón P, Rubio Terrés C, Guallar E.

Pharmacoeconomics. 1999 Jan;15(1):75-83.

PMID:
10345159
9.

The burden of Haemophilus influenzae type b disease in Australia and an economic appraisal of the vaccine PRP-OMP.

Harris A, Hendrie D, Bower C, Payne J, de Klerk N, Stanley F.

Med J Aust. 1994 Apr 18;160(8):483-8.

PMID:
8170423
10.

An economic analysis of alternatives for childhood immunisation against Haemophilus influenzae type b disease.

McIntyre P, Hall J, Leeder S.

Aust J Public Health. 1994 Dec;18(4):394-400.

PMID:
7718653
11.

Economic evaluation of Haemophilus influenzae type B vaccination in Indonesia: a cost-effectiveness analysis.

Broughton EI.

J Public Health (Oxf). 2007 Dec;29(4):441-8. Epub 2007 Sep 17.

PMID:
17875589
12.

Impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccination in India.

Clark AD, Griffiths UK, Abbas SS, Rao KD, Privor-Dumm L, Hajjeh R, Johnson H, Sanderson C, Santosham M.

J Pediatr. 2013 Jul;163(1 Suppl):S60-72. doi: 10.1016/j.jpeds.2013.03.032.

13.

[The cost-effectiveness of Haemophilus influenzae type b vaccine for children under 2 years of age in Colombia].

Alvis Guzmán N, De La Hoz Restrepo F, Vivas Consuelo D.

Rev Panam Salud Publica. 2006 Oct;20(4):248-55. Spanish.

PMID:
17316483
14.

New vaccines against otitis media: projected benefits and cost-effectiveness.

O'Brien MA, Prosser LA, Paradise JL, Ray GT, Kulldorff M, Kurs-Lasky M, Hinrichsen VL, Mehta J, Colborn DK, Lieu TA.

Pediatrics. 2009 Jun;123(6):1452-63. doi: 10.1542/peds.2008-1482.

PMID:
19482754
15.

Cost-effectiveness of Haemophilus influenzae type b conjugate vaccine program in Florida.

Midani S, Ayoub EM, Rathore MH.

J Fla Med Assoc. 1995 Jun;82(6):401-2.

PMID:
7643054
16.

Economic evaluation of Haemophilus influenzae type b vaccination in Moscow, Russian Federation.

Platonov AE, Griffiths UK, Voeykova MV, Platonova OV, Shakhanina IL, Chistyakova GG, Robertson SE; Moscow Hib Study Team.

Vaccine. 2006 Mar 20;24(13):2367-76. Epub 2005 Dec 15.

PMID:
16413949
18.
19.

Economic evaluation of general childhood vaccination against Haemophilus influenzae type b in Sweden.

Garpenholt O, Silfverdal SA, Levin LA.

Scand J Infect Dis. 1998;30(1):5-10.

PMID:
9670351
20.

Cost-effectiveness of Haemophilus influenzae type b (Hib) vaccine introduction in the universal immunization schedule in Haryana State, India.

Gupta M, Prinja S, Kumar R, Kaur M.

Health Policy Plan. 2013 Jan;28(1):51-61. doi: 10.1093/heapol/czs025. Epub 2012 Mar 8.

PMID:
22407018

Supplemental Content

Support Center